(Sharecast News) - American pharma giant. Eli Lilly and Co on Tuesday announced three acquisitions to beef up its infectious diseases portfolio, spending a combined $3.83bn to buy Curevo, LimmaTech Biologics and Vaccine Company.
The three companies have developed treatments to address viral pathogens linked to long-term neurological and oncological risk,...

Email this article to a friend

or share it with one of these popular networks:

• DIGG
• FACEBOOK
• STUMBLEUPON
• MIXX
• YAHOO BUZZ
• DELICIOUS
• REDDIT
• NEWSVINE